Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Xoma, Genentech to collaborate on anti-CD11a

May 3, 1996

Dermatology drugs in the BMS pipeline

April 26, 1996

Hyal-CT1101 effective in phase III trial

April 26, 1996

Iamin gel in phase I in Japan

April 26, 1996

Teva's generic minoxidil approved in U.S.

April 19, 1996

Azelex now available to treat acne

April 12, 1996

ALA-PDT to be studied for hair removal

April 12, 1996

Silkis licensed to Galderma

April 12, 1996

ADCON-L efficacy reported

April 5, 1996

New 5alpha-reductase inhibitor from Merck & Co.

March 26, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...